Diloxanide furoate: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) m (Protected "Diloxanide furoate": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Diloxanide furoate''' is an anti-protozoal drug used in the treatment of [[Entamoeba histolytica]] and some other protozoal infections. | '''Diloxanide furoate''' is an anti-protozoal drug used in the treatment of [[Entamoeba histolytica]] and some other protozoal infections. | ||
| Line 15: | Line 15: | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 00:46, 9 August 2012
Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections.
Safety and Effectiveness
A 13-year study conducted by the United States Center for Disease Control between 1977 and 1990 found that this drug had a low incidence of side effects and was successful in treatment of 86% of asymptomatic carriers of Entamoeba histolytica. [1]
Availability by Country
United States: Not currently approved for use. A CDC study authorized the use of this drug in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990. [1]